More evidence for the therapeutic role of pramipexole in upper limb restlessness due to cervical disc pathology?

dc.authorid0000-0002-9704-6173
dc.authorid0000-0003-4292-5717
dc.contributor.authorYuluğ, Burak
dc.contributor.authorHanoğlu, Lütfü
dc.contributor.authorBrandmeier, Sema
dc.date.accessioned10.07.201910:49:13
dc.date.accessioned2019-07-10T19:51:40Z
dc.date.available10.07.201910:49:13
dc.date.available2019-07-10T19:51:40Z
dc.date.issued2018
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Nöroloji Ana Bilim Dalı
dc.departmentİstanbul Medipol Üniversitesi, Rektörlük, Rejeneratif ve Restoratif Tıp Araştırmaları Merkezi (REMER)
dc.descriptionWOS: 000442221000009
dc.descriptionPubMed ID: 29493461
dc.description.abstractBackground: The causal link between upper limb restlessness and cervical disc prolapsus is still unclear, and the exact role of the spinal cord in the origination of limb restlessness is not yet completely understood. Methods: Here we have evaluated the therapeutic effect of pramipexole (0.5mg/kg) in a 47-year old male with cervical disc prolapsus who described restlessness in his upper limb and neck. Results: The patient felt significantly better, and his symptoms improved near to complete after five days when we initiated 0.5mg/day pramipexole treatment. Conclusion: In our present paper, we provide more evidence for the role of pramipexole (0.5mg/day) in limb restlessness which is associated with cervical disc herniation. In this context, we also have discussed the underlying pathophysiology which seems to be responsible for the restlessness symptoms of the patients.
dc.identifier.citationYuluğ, B., Hanoğlu, L. ve Brandmeier, S. (2018). More evidence for the therapeutic role of pramipexole in upper limb restlessness due to cervical disc pathology? Current Clinical Pharmacology, 13(1), 73-74. https://dx.doi.org/10.2174/1574884713666180227165917
dc.identifier.doi10.2174/1574884713666180227165917
dc.identifier.endpage74
dc.identifier.issn1574-8847
dc.identifier.issn2212-3938
dc.identifier.issue1
dc.identifier.scopusqualityQ1
dc.identifier.startpage73
dc.identifier.urihttps://dx.doi.org/10.2174/1574884713666180227165917
dc.identifier.urihttps://hdl.handle.net/20.500.12511/2261
dc.identifier.volume13
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherBentham Science Publ Ltd
dc.relation.ispartofCurrent Clinical Pharmacologyen_US
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/embargoedAccess
dc.subjectCervical Disc Herniation
dc.subjectArm Restlessness
dc.subjectSensorimotor
dc.subjectSpinal Hyperexcitability
dc.subjectSpinal Dopaminergic Tracts
dc.subjectMyelopathy
dc.titleMore evidence for the therapeutic role of pramipexole in upper limb restlessness due to cervical disc pathology?
dc.typeLetter

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
Yuluğ, B..pdf
Boyut:
2.6 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text